Continuous glucose monitoring for cystic fibrosis-related diabetes: impact on quality of life and glycaemic control
Open Access
- 20 April 2026
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 236, 113274
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis in Australia
This publication has 12 references indexed in Scilit:
- Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysisDiabetologia, 2024
- The presence of cystic fibrosis-related diabetes modifies the sputum microbiome in cystic fibrosis diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2024
- Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative reviewDiabetic Medicine, 2022
- Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: A systematic review and meta-analysisJournal of Cystic Fibrosis, 2022
- Updated Software for Automated Assessment of Glucose Variability and Quality of Glycemic Control in DiabetesDiabetes Technology & Therapeutics, 2020
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Diabetes-related Mortality in Adults with Cystic Fibrosis. Role of Genotype and SexAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosisJournal of Cystic Fibrosis, 2007